Key summary of German national treatment guidance for hospitalized COVID-19 patients

URN to cite this document:: urn:nbn:de:bvb:355-epub-569202
DOI to cite this document:: 10.5283/epub.56920

Malin, Jakob J.

; Spinner, Christoph D. ; Janssens, Uwe ; Welte, Tobias ; Weber-Carstens, Steffen

; Schälte, Gereon ; Gastmeier, Petra ; Langer, Florian ; Wepler, Martin

; Westhoff, Michael ; Pfeifer, Michael ; Rabe, Klaus F.

; Hoffmann, Florian ; Böttiger, Bernd W. ; Weinmann-Menke, Julia ; Kersten, Alexander ; Berlit, Peter ; Krawczyk, Marcin

; Nehls, Wiebke ; Fichtner, Falk ; Laudi, Sven ; Stegemann, Miriam

; Skoetz, Nicole ; Nothacker, Monika

; Marx, Gernot ; Karagiannidis, Christian ; Kluge, Stefan

License: Creative Commons Attribution 4.0
PDF - Published Version
(919kB)

Date of publication of this fulltext: 29 Feb 2024 12:42

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Purpose This executive summary of a national living guideline aims to provide rapid evidence based recommendations on the role of drug interventions in the treatment of hospitalized patients with COVID-19. Methods The guideline makes use of a systematic assessment and decision process using an evidence to decision framework (GRADE) as recommended standard WHO (2021). Recommendations are ...